₹18.50
−6.99%BSE close, 16 Nov 2026
−61.31%
Vanta Bioscience is a small cap company in the Healthcare sector, listed on BSE SME under the symbol VANTABIO (BSE code 540729). At ₹18.50 a share, the market values the whole company at ₹13 crore. BSE SME is the exchange's platform for small and medium companies, which report their results every half year.
Over the past year the share price has fallen 33.2%, and it is 33.0% below its 52-week high.
Companies of a similar size in the same sector include GENOMIC VALLEY BIOTECH, VENMAX DRUGS AND PHARMACEUTICA, Global Longlife Hospital and R and STARSOURCE MULTITRADE.
Listed on BSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
This company is listed only on BSE, so its page shows price figures only: results and shareholding on RupeeVerse come from companies’ NSE filings.
The same sector (Healthcare), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| Vanta Bioscience | ₹18.50 | ₹13 cr | n/a | n/a | n/a | −33.19% |
| GENOMIC VALLEY BIOTECH | ₹47.00 | ₹14 cr | n/a | n/a | n/a | +51.56% |
| VENMAX DRUGS AND PHARMACEUTICA | ₹12.36 | ₹14 cr | n/a | n/a | n/a | −55.60% |
| Global Longlife Hospital and R | ₹13.53 | ₹14 cr | n/a | n/a | n/a | −42.96% |
| STARSOURCE MULTITRADE | ₹91.75 | ₹14 cr | n/a | n/a |
| n/a |
| −22.28% |
| DESH RAKSHAK AUSHDHALAYA | ₹23.50 | ₹13 cr | n/a | n/a | n/a | −34.17% |
|---|
| UNJHA FORMULATIONS | ₹27.87 | ₹12 cr | n/a | n/a | n/a | +21.23% |
|---|
| BERYL DRUGS | ₹24.59 | ₹12 cr | n/a | n/a | n/a | +6.45% |
|---|
| DOLPHIN MEDICAL SERVICES | ₹7.83 | ₹12 cr | n/a | n/a | n/a | +274.64% |
|---|